Epilepsy trials recruiting in California

All Epilepsy trials nationally

Cities in California

Recruiting trials in California

• A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
  NCT05419492 · Phase: Phase 1, Phase 2 · Ages: 6 Months to 17 Years · Sex: All (male and female) · California: San Francisco
• A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
  NCT07019922 · Phase: Phase 3 · Ages: 1 Day to 18 Years · Sex: All (male and female) · California: San Diego
• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · California: Los Angeles, Orange, San Francisco
• A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
  NCT07227857 · Phase: Phase 1, Phase 2 · Ages: 2 Years to 12 Years · Sex: All (male and female) · California: Orange
• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
  NCT06422923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Los Angeles, Orange, Palo Alto, San Diego
• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
  NCT06660394 · Phase: Phase 3 · Ages: 2 Years to 65 Years · Sex: All (male and female) · California: Los Angeles, Palo Alto, San Francisco
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
  NCT05716100 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Downey, Los Angeles, Orange
• A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
  NCT06388707 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · California: Los Angeles, Orange, San Francisco
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: La Jolla, Los Angeles, Palo Alto, Pasadena
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Los Angeles, Orange, Sacramento
• A Study to Prevent Infantile Spasms Relapse
  NCT06819670 · Phase: Phase 2 · Ages: 2 Months to 18 Months · Sex: All (male and female) · California: Los Angeles
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Palo Alto
• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
  NCT05066217 · Phase: Phase 3 · Ages: 2 Years to 55 Years · Sex: All (male and female) · California: Orange
• Brain Development Research Program
  NCT00305305 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: San Francisco
• Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS)
  NCT07663578 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Sacramento
• Congenital Muscle Disease Study of Patient and Family Reported Medical Information
  NCT01403402 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Lakewood
• Diagnosing Epilepsy To EffeCT Change
  NCT07110337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Irvine, Palo Alto
• Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
  NCT07110454 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Palo Alto
• Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
  NCT06608966 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 17 Years · Sex: All (male and female) · California: Orange
• Epilepsy Learning Healthcare System (ELHS)
  NCT06265103 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · California: Palo Alto
• Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans
  NCT05996900 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Stanford
• Model-based Electrical Brain Stimulation
  NCT05327387 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
  NCT07680842 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 65 Years · Sex: All (male and female) · California: San Francisco
• North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
  NCT01694940 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: San Diego, Stanford
• Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States
  NCT07110688 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Downey, Los Angeles
• Prospective Natural History Study of POLG Disease
  NCT07775872 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: San Diego
• STXBP1 and SYNGAP1 Related Disorders Natural History Study
  NCT06555965 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Palo Alto
• Sleep Architecture & Cognition in Focal Epilepsy
  NCT05794295 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · California: Sacramento
• Spatial Scene Recognition Memory in Epilepsy Surgery
  NCT07580183 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: Sacramento
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
  NCT05104983 · Phase: Phase 2 · Ages: 1 Day to 6 Months · Sex: All (male and female) · California: Los Angeles, Palo Alto
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
  NCT07563881 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Palmdale
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Los Angeles, Orange, Palo Alto, Sacramento
• Treatment of Refractory Infantile Spasms With Fenfluramine
  NCT04289467 · Phase: Phase 2 · Ages: 12 Months to 36 Months · Sex: All (male and female) · California: Los Angeles, Orange
• Understanding Ketamine's Dissociative Effects (KD Study)
  NCT04861051 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto
• Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
  NCT05283811 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 64 Years · Sex: All (male and female) · California: Los Angeles